TW200500060A - Composition and use of allylamine derivatives - Google Patents

Composition and use of allylamine derivatives

Info

Publication number
TW200500060A
TW200500060A TW093107303A TW93107303A TW200500060A TW 200500060 A TW200500060 A TW 200500060A TW 093107303 A TW093107303 A TW 093107303A TW 93107303 A TW93107303 A TW 93107303A TW 200500060 A TW200500060 A TW 200500060A
Authority
TW
Taiwan
Prior art keywords
allylamine derivatives
composition
inhibition
allylamine
derivatives
Prior art date
Application number
TW093107303A
Other languages
English (en)
Inventor
Wen-Sen Lee
Rong-Jane Chen
Ying-Jan Wang
How Tseng
Jiiang-Huei Jeng
Shyr Yi Lin
Yu Chih Liang
Chien Ho Chen
Chien Huang Lin
Jen Kun Lin
Pei Yin Ho
Jan Show Chu
Wei Lu Ho
Li Ching Chen
Yuan Soon Ho
Original Assignee
Tty Biopharm Co Ltd
Yuan Soon Ho
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tty Biopharm Co Ltd, Yuan Soon Ho filed Critical Tty Biopharm Co Ltd
Publication of TW200500060A publication Critical patent/TW200500060A/zh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TW093107303A 2003-08-08 2004-03-18 Composition and use of allylamine derivatives TW200500060A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/637,931 US20050032904A1 (en) 2003-08-08 2003-08-08 Composition and use of allylamine derivatives

Publications (1)

Publication Number Publication Date
TW200500060A true TW200500060A (en) 2005-01-01

Family

ID=34116684

Family Applications (1)

Application Number Title Priority Date Filing Date
TW093107303A TW200500060A (en) 2003-08-08 2004-03-18 Composition and use of allylamine derivatives

Country Status (3)

Country Link
US (1) US20050032904A1 (zh)
CN (1) CN1579379A (zh)
TW (1) TW200500060A (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100364520C (zh) * 2006-04-24 2008-01-30 魏锐 盐酸特比萘芬栓剂及其制备方法
AU2012321107A1 (en) * 2011-10-20 2013-05-16 The Curators Of The University Of Missouri Enzyme inhibitor for cancer treatment

Also Published As

Publication number Publication date
US20050032904A1 (en) 2005-02-10
CN1579379A (zh) 2005-02-16

Similar Documents

Publication Publication Date Title
HK1079522A1 (en) Thienyl compounds
HK1079519A1 (en) Furyl compounds
MXPA03005893A (es) Proteccion, restauracion, y mejora de celulas, tejidos y organos que responden a la eritropoyetina.
EP1478406A4 (en) COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS AND OTHER MATERIALS AND METHOD FOR THE PRODUCTION AND USE THEREOF
IT1333697B (zh)
SG150559A1 (en) Antineoplastic combinations of cci-779 and rituximab
HK1080470A1 (en) Heterocyclic compounds
PL1742644T3 (pl) Kompozycja terapeutyczna zawierająca co najmniej jedną pochodną pirolobenzodiazepiny i fludarabiny
TW200621268A (en) Antimicrobial copolymers and uses thereof
WO2004034990A3 (en) Methods and compositions for use in treating cancer
IL173785A0 (en) Anti-tumor formulations comprising defibrotide alone or in combination with other anti-tumor agents
EP1392328A4 (en) ANTICANCER THERAPY
HK1057336A1 (en) Pharmaceutical solutions of modafinil compounds
MXPA04001256A (es) Productos de combinacion de derivados de propanolamina aril substituidos con otros ingredientes activos y su uso.
WO2004087098A3 (en) Preserved ophthalmic compositions
HK1033910A1 (en) Use of erythropoietin in the treatment of multiple myeloma
EP1383516A4 (en) CO-ADMINISTRATION OF A POLYSACCHARIDE WITH A CHEMOTHERAPEUTIC AGENT FOR THE TREATMENT OF CANCER
MX2007011381A (es) Composicion de espirulinas rica en principios activos, su proceso de obtencion y su utilizacion.
TW200500060A (en) Composition and use of allylamine derivatives
HK1079116A1 (en) Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and radiotherapy
MXPA05013121A (es) Derivados de indol con efecto de induccion de apoptosis.
MXPA04005942A (es) Composiciones y metodos de sintaxina 3.
MY141606A (en) N-alkoxyalkyl-substituted benzimidazoles, their preparation and their use as agents against parasitic protozoa
MXPA03002494A (es) Metodo para reducir toxicidad de quimio terapias combinadas.
GEP20115184B (en) Pharmacokinetically improved compounds